Biotech entity

NHS

organization

pharma accounts for 5 of the 6 tracked stories, while 1 other category carries the remainder. Department of Health and Social Care is the most frequent co-covered peer, appearing in 2 of the 6 tracked stories. Negative sentiment reaches 33% here, compared with 19% across the 329-story beat baseline for the same window.

Last mentioned: Jul 12, 2026

Entity pulse

Recent coverage · NHS

6 stories
6.5 avg impact
17% positive
33% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 16 percentage points.

  • 17% positive
  • 50% neutral
  • 33% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about NHS

pharma accounts for 5 of the 6 tracked stories, while 1 other category carries the remainder. Department of Health and Social Care is the most frequent co-covered peer, appearing in 2 of the 6 tracked stories. Negative sentiment reaches 33% here, compared with 19% across the 329-story beat baseline for the same window. Across a 109-day span, the pace is roughly 0.4 stories per week. Source depth averages 3.7 original sources per story, versus 3.4 across the same-window beat baseline. The 6.5 average consequence score is above the beat benchmark of 6.2 in the same window. NHS appears in 6 tracked Biotech stories published from March 6, 2026 through June 22, 2026.

Stories tracked
6
Per week
0.4
Negative
33%
Sources per story
3.7

Computed from the 6 stories linked to this entity, with beat comparisons drawn from all 329 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering NHS. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Elimination Target

    The UK's target date for the total elimination of cervical cancer.

  2. Scheduled Re-evaluation

    NICE appraisal committee is set to meet for a second round of evidence review.

  3. Regional Review

    NHS Hertfordshire to assess uptake data from the March vaccination push.

  4. NHS Impact Probe

    The inquiry sets out detailed evidence regarding the pandemic's impact on NHS patients and staff.

  5. NHS Alert Issued

    A formal alert is sent to NHS trusts and GP surgeries across England to prepare for increased vaccine demand.

  6. Vaccination Rollout

    Student-focused clinics begin administering MenACWY doses in university towns.

  7. Weekend Clinic Launch

    First round of weekend vaccination sessions begins in Hatfield.

  8. Surveillance Data Review

    UKHSA identifies a rising trend in meningococcal strain activity among young adults.

  9. Campaign Announcement

    Local news outlets report on the Hatfield clinic's participation in the HPV drive.

  10. Public Campaign Launch

    Bereaved family launches a national campaign imploring the NHS to reconsider the approval.

  11. NICE Initial Review

    NICE issues a preliminary recommendation against the drug due to cost-effectiveness concerns.

  12. FDA Approval

    The treatment receives accelerated approval in the United States for aggressive cancer types.

  13. Module 3 Hearings Begin

    Public hearings start for the module focused on the impact on healthcare systems.

  14. Inquiry Established

    The UK COVID-19 Inquiry is formally set up to examine the UK's response to the pandemic.

  15. First National Lockdown

    UK government imposes stay-at-home orders, significantly impacting NHS service delivery.

Stories mentioning NHS 6

Pharma Neutral

UK COVID-19 Inquiry Shifts Focus to NHS Impact and Healthcare Resilience

The UK’s public inquiry into the COVID-19 pandemic has entered a critical phase, examining the systemic impact on the National Health Service (NHS) and patient outcomes. This module scrutinizes healthcare capacity, the management of non-COVID services, and the effectiveness of medical interventions during the crisis.

3 sources
Pharma Neutral

NHS Issues Meningitis Alert as Student Vaccination Campaign Intensifies

The NHS has issued an urgent health alert across England as students begin receiving critical meningitis vaccinations to combat a seasonal rise in invasive meningococcal disease. Health officials are prioritizing first-year university students to prevent potential outbreaks in high-density campus environments.

2 sources
Pharma Neutral

Hatfield Clinic Joins NHS Hertfordshire HPV Vaccination Drive for Under-25s

A Hatfield-based clinic is launching a targeted weekend vaccination initiative as part of a broader NHS Hertfordshire campaign to increase HPV immunization rates among young adults. The program specifically targets individuals under 25 to close immunity gaps and support long-term cancer prevention goals.

2 sources
Pharma Strongly negative

Fatal Bacterial Outbreak Linked to Wet Wipes Claims Six Lives in UK

A public health crisis has emerged following six confirmed deaths linked to a fatal bacterial contamination in wet wipes. UK health authorities have launched an urgent investigation into manufacturing protocols and supply chain integrity to contain the outbreak.

2 sources

NHS is linked from 6 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.